Microbiology of surgical site infections in abdominal tract surgery patients.;Microbiología de las infecciones del sitio quirú rgico en pacientes intervenidos del tracto digestivo

Cirugia Espanola

Volumn 89, Issue 9, 2011, Pages 606-612

  Múñez, Elena ^a   Ramos, Antonio ^a   Espejo, Teresa Álvarez de ^a   Vaqué, Josep ^b   Sánchez Payá, José ^c   Pastor, Vicente ^d   Asensio, Ángel ^e  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

General surgery; Methicillin resistant Staphylococcus aureus; Microbiology; Peritonitis; Surgical wound infection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; GASTROINTESTINAL TRACT; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 80055061881     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/j.ciresp.2011.05.008     Document Type: Article

References (40)

1. Kirby J.P., Mazuski J.E. Prevention of surgical site infection. Surg Clin North Am 2009, 89:365-389.
2. Emori T.G., Gaynes R.P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993, 6:428-442.
3. Smith R.L., Bohl J.K., McElearney S.T., Friel C.M., Barclay M.M., Sawyer R.G., et al. Wound infection after elective colorectal resection. Ann Surg 2004, 239:599-607.
4. Fry D.E. The economic costs of surgical site infection. Surg Infect (Larchmt) 2002, 3(Suppl 1):S37-S43.
5. Pessaux P., Msika S., Atalla D., Hay J.M., Flamant Y. French Association for Surgical Research Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg 2003, 138:314-324.
6. Culver D.H., Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991, 91:152-157. Suppl 3B.
7. Edwards J.R., Peterson K.D., Andrus M.L., Dudeck M.A., Pollock D.A., Horan T.C. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008, 36:609-626. National Healthcare Safety Network Facilities.
8. Haridas M., Malangoni M.A. Predictive factors for surgical site infection in general surgery. Surgery 2008, 144:496-501.
9. Iñigo J.J., Bermejo B., Oronoz B., Herrera J., Tarifa A., Pérez F., et al. Infección de sitio quirúrgico en un servicio de cirugía general. Análisis de cinco años y valoración del índice National Nosocomial Infection Surveillance (NNIS). Cir Esp 2006, 79:224-230.
10. Weiss C.A., Statz C.L., Dahms R.A., Remucal M.J., Dunn D.L., Beilman G.J. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999, 134:1041-1048.
11. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999, 20:250-278.
12. Augustin P., Kermarrec N., Muller-Serieys C., Lasocki S., Chosidow D., Marmuse J.P., et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 2010, 14:R20. Epub 2010 Feb 15.
13. Montravers P., Lepape A., Dubreuil L., Gauzit R., Pean Y., Benchimol D., et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009, 63:785-794.
14. Guirao X., Arias J., Badía J.M., García-Rodríguez J.A., Mensa J., Alvarez-Lerma F., et al. Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal. Cir Esp 2010, 87:63-81.
15. Asensio A., Cantón R., Vaqué J., Rosselló J., Arribas J.L. Etiología de las infecciones hospitalarias en España (EPINE, 1990-1999). Med Clin (Barc) 2002, 118:725-730.
16. Horan T.C., Gaunes R.P., Martone W.J., Jarvis W.R., Emori T.G. CDC definitions of nosocomial surgical site infection, 1992. A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13:606-608.
17. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
18. Vázquez-Aragon P., Lizan-García M., Cascales-Sánchez P., Villar-Canovas M.T., Garcia-Olmo D. Nosocomial infection and related risk factors in a general surgery service: a prospective study. J Infect 2003, 46:17-22.
19. Schnüriger B., Inaba K., Eberle B.M., Wu T. Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg 2010, 14:1304-1310.
20. Mosdell D., Morris D., Voltura A., Pitcher D., Twiest M., Milne R., et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991, 214:543-549.
21. Tellado J., Sen S., Caloto M., Kumar R., Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis 2007, 39:947-955.
22. Roehrborn A., Thomas L., Potreck O., Ebener C., Ohmann C., Goretzki P.E., et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001, 33:1513-1519.
23. Cisneros J.M., Rodríguez-Baño J., Mensa J., Trilla A., Cainzos M. Profilaxis con antimicrobianos en cirugía. Enferm Infecc Microbiol Clin 2002, 20:335-340.
24. Dahms R.A., Johnson E.M., Statz C.L., Lee J.T., Dunn D.L., Beilman G.J., et al. Third generation cephalo-sporins and vancomycin as risk factors for postoperative vancomycin resistant enterococcus infection. Arch Surg 1998, 133:1343-1346.
25. Cercenado E., Torroba L., Cantón R., Martínez-Martínez L., Chaves F., García-Rodríguez J.A., et al. Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol 2010, 48:456-459.
26. Burnett R., Haverstock D., Dellinger E., Reinhart H.H., Bohnen J.M., Rotstein O.D., et al. Definition of the role of Enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 1995, 118:716-723.
27. Sitges-Serra A., Lopez M., Girvent M., Almirall S., Sancho J. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 2002, 89:361-367.
28. Berthelot P., Grattard F., Mahul P., Pain P., Jospé R., Venet C., et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 2001, 27:503-512.
29. Kumar A., Roberts D., Wood K., Light B., Parrillo J., Sharma S., et al. Duration of hypotension before initiation of effective anti-microbial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
30. Solomkin J.S., Mazuski J.E., Baron E.J., Sawyer R.G., Nathens A.B., DiPiro J.T., et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003, 37:997-1005.
31. Qadan M., Cheadle W.G. Common microbial pathogens in surgical practice. Surg Clin North Am 2009, 89:295-310.
32. Swenson B.R., Metzger R., Hedrick T.L., McElearney S.T., Evans H.L., Smith R.L., et al. Choosing antibiotics for intra-abdominal infections: what do we mean by «high risk»?. Surg Infect (Larchmt) 2009, 10:29-39.
33. Montravers P., Dupont H., Gauzit R., Veber B., Auboyer C., Blin P., et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006, 34:646-652.
34. Nolla-Salas J., Sitges-Serr aA, León-Gil C., Martínez-González J., León-Regidor M., Ibáñez-Lucia P., et al. Candidemia in non- neutropenic critically ill patients: análisis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997, 23:23-30.
35. Vincent J., Anaissie E., Bruining H., Demajo W., el-Ebiary M., Haber J., et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients underintensive care. Intensive Care Med 1998, 24:206-216.
36. Baré M., Castells X., García A., Riu M., Comas M., Gil-Egea M. Importance of apopropiateness of empirical antibiotictherapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Healt Care 2006, 22:242-248.
37. Sturkenboom M., Goettsch W., Picelli G., Veld B., Yin D., de Jong R., et al. Inappropiate initial treatment of secondary intra- abdomial infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005, 60:438-443.
38. Ibrahim E., Sherman G., Ward S., Frase V., Kollef M. The influence of inadequate antimicrobial treatment of bloods-tream infections on patients outcomes in the ICU setting. Chest 2000, 118:146.
39. Baquero F., Cecenado E., Cisterna R., M.de la Rosa M., García-Rodríguez J.A., Gobernado M., et al. Patrones de sensiblidad a antimicrobianos en enterobacterias causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003. Rev Esp Quimioter 2006, 19:51-59.
40. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum b-lactamase producing enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(Supl. 1):144-153.